Back
Black Diamond Therapeutics Stock Price Chart
Sponsored
BDTX
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
43
BDTX
Black Diamond Therapeutics
Last Price:
4.76
Seasonality Move:
-21.92%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDTX is experiencing slight selling pressure.
Black Diamond Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.5 | Sell |
20-day SMA: | 5.8 | Sell |
50-day SMA: | 5.7 | Sell |
200-day SMA: | 4.77 | Buy |
8-day EMA: | 5.27 | Sell |
20-day EMA: | 5.55 | Sell |
50-day EMA: | 5.57 | Sell |
200-day EMA: | 4.85 | Sell |
Black Diamond Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 38.53 | Sell |
Chaikin Money Flow: | -186606 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.23 - 6.31) | Sell |
Bollinger Bands (100): | (4.8 - 6.22) | Sell |
Black Diamond Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Black Diamond Therapeutics Stock
Is Black Diamond Therapeutics Stock a Buy?
- Black Diamond Therapeutics share price is 4.78 while BDTX 8-day simple moving average is 5.50, which is a Sell signal.
- The stock price of BDTX is 4.78 while Black Diamond Therapeutics 20-day SMA is 5.80, which makes it a Sell.
- Black Diamond Therapeutics 50-day simple moving average is 5.70 while BDTX share price is 4.78, making it a Sell technically.
- BDTX stock price is 4.78 and Black Diamond Therapeutics 200-day simple moving average is 4.77, creating a Buy signal.
BDTX Technical Analysis vs Fundamental Analysis
Sell
43
Black Diamond Therapeutics (BDTX)
is a Sell
Is Black Diamond Therapeutics a Buy or a Sell?
-
Black Diamond Therapeutics stock is rated a Sell
The current Black Diamond Therapeutics [BDTX] share price is $4.78. The Score for BDTX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Black Diamond Therapeutics Stock Info
Market Cap:
270.09M
Price in USD:
4.78
Share Volume:
719.77K
Black Diamond Therapeutics 52-Week Range
52-Week High:
7.66
52-Week Low:
1.62
Sell
43
Black Diamond Therapeutics (BDTX)
is a Sell
Black Diamond Therapeutics Share Price Forecast
-
What is the Black Diamond Therapeutics stock price today?
The Black Diamond Therapeutics stock price is 4.78 USD today. -
Will BDTX stock go up or go down?
Black Diamond Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Black Diamond Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Black Diamond Therapeutics is overvalued.
Is Black Diamond Therapeutics Stock a Buy?
- Black Diamond Therapeutics share price is 4.78 while BDTX 8-day exponential moving average is 5.27, which is a Sell signal.
- The stock price of BDTX is 4.78 while Black Diamond Therapeutics 20-day EMA is 5.55, which makes it a Sell.
- Black Diamond Therapeutics 50-day exponential moving average is 5.57 while BDTX share price is 4.78, making it a Sell technically.
- BDTX stock price is 4.78 and Black Diamond Therapeutics 200-day simple moving average is 4.85, creating a Sell signal.
Fundamental Analysis of Black Diamond Therapeutics
Is Black Diamond Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.57 per share, and a decrease next year of $0.14 per share.
Technical Analysis of Black Diamond Therapeutics
Should I short Black Diamond Therapeutics stock?
- BDTX Moving Average Covergence Divergence (MACD) indicator is -0.16, suggesting Black Diamond Therapeutics is a Sell
- Black Diamond Therapeutics Relative Strength Index (RSI) is 38.53, which suggest Black Diamond Therapeutics is oversold
- The Bollinger Bands (25) for Black Diamond Therapeutics is (5.23 - 6.31), which suggest Black Diamond Therapeutics is a Sell
- The Bollinger Bands (100) for Black Diamond Therapeutics is (4.8 - 6.22), which suggest Black Diamond Therapeutics is a Sell
* Black Diamond Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.